XML 38 R25.htm IDEA: XBRL DOCUMENT
v3.24.2.u1

REVENUES (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2024
REVENUES |
Schedule of revenues disaggregated by category | Revenues disaggregated by category were as follows (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | Six Months Ended June 30,
​ | ​ | 2024 |  | 2023 | ​ | 2024 |  | 2023
Product sales: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Gross product sales | ​ | $ | 48,980 | ​ | $ | 33,456 | ​ | $ | 87,406 | ​ | $ | 66,654
Discounts and allowances | ​ | ​ | (15,530) | ​ | ​ | (9,575) | ​ | ​ | (27,953) | ​ | ​ | (19,028)
Total product sales, net | ​ | ​ | 33,450 | ​ | ​ | 23,881 | ​ | ​ | 59,453 | ​ | ​ | 47,626
Revenues from collaborations: | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Delivery of drug supplies, royalty and others | ​ | ​ | 3,391 | ​ | ​ | 2,005 | ​ | ​ | 6,922 | ​ | ​ | 4,330
Total revenues from collaborations | ​ | ​ | 3,391 | ​ | ​ | 2,005 | ​ | ​ | 6,922 | ​ | ​ | 4,330
Government contracts | ​ | ​ | — | ​ | ​ | 1,000 | ​ | ​ | — | ​ | ​ | 1,000
Total revenues | ​ | $ | 36,841 | ​ | $ | 26,886 | ​ | $ | 66,375 | ​ | $ | 52,956
Schedule of product revenue allowance and reserve categories |
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Chargebacks, | ​ | Government | ​ | ​ | ​ | ​
​ | ​ | Discounts and | ​ | and Other | ​ | ​ | ​ | ​
​ | ​ | Fees | ​ | Rebates | ​ | Returns | ​ | Total
Balance as of January 1, 2024 |  | $ | 8,236 | ​ | $ | 3,517 | ​ | $ | 3,931 | ​ | $ | 15,684
Provision related to current period sales | ​ | ​ | 21,770 | ​ | ​ | 5,259 | ​ | ​ | 522 | ​ | ​ | 27,551
Credit or payments made during the period | ​ | ​ | (20,165) | ​ | ​ | (4,441) | ​ | ​ | (82) | ​ | ​ | (24,688)
Balance as of June 30, 2024 |  | $ | 9,841 | ​ | $ | 4,335 | ​ | $ | 4,371 | ​ | $ | 18,547
​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Chargebacks, | ​ | Government | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Discounts and | ​ | and Other | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Fees | ​ | Rebates | ​ | Returns | ​ | Total
Balance as of January 1, 2023 |  | $ | 6,213 | ​ | $ | 2,636 | ​ | $ | 3,296 | ​ | $ | 12,145
Provision related to current period sales | ​ | ​ | 14,439 | ​ | ​ | 3,725 | ​ | ​ | 395 | ​ | ​ | 18,559
Credit or payments made during the period | ​ | ​ | (13,139) | ​ | ​ | (3,765) | ​ | ​ | (116) | ​ | ​ | (17,020)
Balance as of June 30, 2023 |  | $ | 7,513 | ​ | $ | 2,596 | ​ | $ | 3,575 | ​ | $ | 13,684
Schedule of revenues from product sales disaggregated by customers | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Three Months Ended June 30, | ​ | ​ | Six Months Ended June 30,
​ | ​ | 2024 |  | 2023 | ​ | ​ | 2024 |  | 2023
McKesson Corporation | ​ | ​ | 49% | ​ | ​ | 44% | ​ | ​ | ​ | 46% | ​ | ​ | 45%
Cardinal Health, Inc. | ​ | ​ | 21% | ​ | ​ | 28% | ​ | ​ | ​ | 22% | ​ | ​ | 26%
Cencora Inc. (formerly ASD Healthcare) | ​ | ​ | 20% | ​ | ​ | 19% | ​ | ​ | ​ | 21% | ​ | ​ | 21%
​

X
- Definition Tabular disclosure of disaggregation of revenue by customer. + References No definition available. + Details
Name: | rigl_DisaggregationOfRevenueByCustomerTableTextBlock
Namespace Prefix: | rigl_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for valuation and qualifying accounts and reserves. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name Regulation S-X (SX) -Number 210 -Section 12 -Subsection 09 -Publisher SEC Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 4 -Subparagraph (SX 210.12-09) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-4 + Details
Name: | srt_ScheduleOfValuationAndQualifyingAccountsDisclosureTextBlock
Namespace Prefix: | srt_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration